Fig. 1From: Fabrication of 6-gingerol, doxorubicin and alginate hydroxyapatite into a bio-compatible formulation: enhanced anti-proliferative effect on breast and liver cancer cellsTEM images of a neat drug carrier (m-HAP), b 6-Gin-M-HAP, c Dox-m-HAP and d 6-Gin + Dox-m-HAPBack to article page